Cargando…

Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial

Community-acquired pneumonia (CAP) is often complicated by elevation of cardiac troponin, a marker of myocardial injury that can be isolated or associated with myocardial infarction (MI). A retrospective study showed that corticosteroid treatment lowers the incidence of MI during the hospital stay....

Descripción completa

Detalles Bibliográficos
Autores principales:	Violi, Francesco, Calvieri, Camilla, Cangemi, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Im - Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223724/ https://www.ncbi.nlm.nih.gov/pubmed/31152308 http://dx.doi.org/10.1007/s11739-019-02117-0

Ejemplares similares

Sex and gender differences in community-acquired pneumonia
por: Corica, Bernadette, et al.
Publicado: (2022)

SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020)

Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis
por: Corica, Bernadette, et al.
Publicado: (2022)

Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays
por: Ishimaru, Naoto, et al.
Publicado: (2021)

Serum TRAIL predicts severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study
por: Hua, Dong-Xu, et al.
Publicado: (2022)

Prevalence and clinical impact of VIral Respiratory tract infections in patients hospitalized for Community-Acquired Pneumonia: the VIRCAP study
por: Tatarelli, P., et al.
Publicado: (2019)

Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality
por: Violi, Francesco, et al.
Publicado: (2021)

Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia
por: Lagi, Filippo, et al.
Publicado: (2020)

RDW-based clinical score to predict long-term survival in community-acquired pneumonia: a European derivation and validation study
por: Melchio, Remo, et al.
Publicado: (2021)

Envisioning simple equitable and mobile-health solutions for complex and diverse needs of women and men with atrial fibrillation
por: Raparelli, Valeria, et al.
Publicado: (2023)

Lower Mortality Rate in Elderly Patients With Community‐Onset Pneumonia on Treatment With Aspirin
por: Falcone, Marco, et al.
Publicado: (2015)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study
por: Pastori, Daniele, et al.
Publicado: (2021)

Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients
por: Bahl, Amit, et al.
Publicado: (2021)

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Performance of non-invasive respiratory function indices in predicting clinical outcomes in patients hospitalized for COVID-19 pneumonia in medical and sub-intensive wards: a retrospective cohort study
por: Cattazzo, Filippo, et al.
Publicado: (2022)

Corticosteroids for community-acquired pneumonia: time to act!
por: Annane, Djillali, et al.
Publicado: (2008)

Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012)

Arguments Against Corticosteroids in Community Acquired Pneumonia
por: de Castro, Felipe Rodríguez, et al.
Publicado: (2011)

Role of modified hydration for preventing contrast-associated acute kidney injury in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention
por: Liu, Lei, et al.
Publicado: (2022)

Endothelial dysfunction is associated with reduced myocardial mechano-energetic efficiency in drug-naïve hypertensive individuals
por: Cefalo, Chiara M. A., et al.
Publicado: (2023)

Lung ultrasound in the follow-up of severe COVID-19 pneumonia: six months evaluation and comparison with CT
por: Russo, Giulia, et al.
Publicado: (2022)

Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience
por: Tascini, Carlo, et al.
Publicado: (2020)

Early echocardiographic findings in patients hospitalized for COVID-19 pneumonia: a prospective, single center study
por: Ceriani, Elisa, et al.
Publicado: (2021)

Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the “less is more” perspective
por: Villani, Rosanna, et al.
Publicado: (2022)

Atrial fibrillation in pneumonia: what clinical implications at long-term?
por: Vitolo, Marco, et al.
Publicado: (2022)

Corticosteroids for all adult patients with community-acquired pneumonia?
por: Spoorenberg, Simone M. C., et al.
Publicado: (2015)

Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016)

Effect of corticosteroids on mortality in patients with community-acquired pneumonia
por: Chen, Shangzhong, et al.
Publicado: (2023)

Radiological lung sequelae, functional status and symptoms in older patients 3 and 6 months after hospitalization for COVID-19 pneumonia
por: Di Pentima, Chiara, et al.
Publicado: (2023)

Handgrip strength is associated with adverse outcomes in patients hospitalized for COVID-19-associated pneumonia
por: Pucci, Giacomo, et al.
Publicado: (2022)

Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection
por: Denegri, Andrea, et al.
Publicado: (2021)

Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients
por: Arcari, Luca, et al.
Publicado: (2020)

Hemoglobin concentration is associated with self-reported disability and reduced physical performance in a community dwelling population of nonagenarians: the Mugello Study
por: Cecchi, Francesca, et al.
Publicado: (2017)

Serological response to COVID-19 pneumonia and increasing severity over 18 months in a prospective cohort of hospitalized patients
por: Grau Gómez, Gemma, et al.
Publicado: (2022)

Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis
por: Cipriani, Alberto, et al.
Publicado: (2020)

Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study
por: Giorgi-Pierfranceschi, Matteo, et al.
Publicado: (2020)

CT score in COVID-19-related pneumonia, the radiologist, and the internist. Trying to unmask who is “the good”, who is “the bad” and who is “the ugly”
por: Crisci, Giulia, et al.
Publicado: (2021)

Renin–angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study
por: Landolfo, Matteo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kjmlmq11sspei36us9sjakjjb4